Interlaboratory study of quality control isolates for a broth microdilution method (Modified CLSI M38-A) for testing susceptibilities of dermatophytes to antifungals

M. A. Ghannoum, B. Arthington-Skaggs, V. Chaturvedi, A. Espinel-Ingroff, M. A. Pfaller, R. Rennie, M. G. Rinaldi, T. J. Walsh

Research output: Contribution to journalArticle

Abstract

The Clinical and Laboratory Standards Institute (CLSI; formerly National Committee for Clinical Laboratory Standards, or NCCLS) M38-A standard for the susceptibility testing of filamentous fungi does not specifically address the testing of dermatophytes. In 2003, a multicenter study investigated the reproducibility of the microdilution method developed at the Center for Medical Mycology, Cleveland, Ohio, for testing the susceptibility of dermatophytes. Data from that study supported the introduction of this method for testing dermatophytes in the future version of the CLSI M38-A standard. In order for the method to be accepted by CLSI, appropriate quality control isolates needed to be identified. To that end, an interlaboratory study, involving the original six laboratories plus two additional sites, was conducted to evaluate potential candidates for quality control isolates. These candidate strains included five Trichophyton rubrum strains known to have elevated MICs to terbinafine and five Trichophyton mentagrophytes strains. Antifungal agents tested included ciclopirox, fluconazole, griseofulvin, itraconazole, posaconazole, terbinafine, and voriconazole. Based on the data generated, two quality control isolates, one T. rubrum isolate and one T. mentagrophytes isolate, were identified and submitted to the American Type Culture Collection (ATCC) for inclusion as reference strains. Ranges encompassing 95.2 to 97.9% of all data points for all seven drugs were established.

Original languageEnglish (US)
Pages (from-to)4353-4356
Number of pages4
JournalJournal of Clinical Microbiology
Volume44
Issue number12
DOIs
StatePublished - Dec 2006
Externally publishedYes

Fingerprint

Arthrodermataceae
terbinafine
Quality Control
Trichophyton
ciclopirox
Mycology
Griseofulvin
Itraconazole
Fluconazole
Antifungal Agents
Multicenter Studies
Fungi
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Microbiology (medical)
  • Microbiology

Cite this

Interlaboratory study of quality control isolates for a broth microdilution method (Modified CLSI M38-A) for testing susceptibilities of dermatophytes to antifungals. / Ghannoum, M. A.; Arthington-Skaggs, B.; Chaturvedi, V.; Espinel-Ingroff, A.; Pfaller, M. A.; Rennie, R.; Rinaldi, M. G.; Walsh, T. J.

In: Journal of Clinical Microbiology, Vol. 44, No. 12, 12.2006, p. 4353-4356.

Research output: Contribution to journalArticle

Ghannoum, MA, Arthington-Skaggs, B, Chaturvedi, V, Espinel-Ingroff, A, Pfaller, MA, Rennie, R, Rinaldi, MG & Walsh, TJ 2006, 'Interlaboratory study of quality control isolates for a broth microdilution method (Modified CLSI M38-A) for testing susceptibilities of dermatophytes to antifungals', Journal of Clinical Microbiology, vol. 44, no. 12, pp. 4353-4356. https://doi.org/10.1128/JCM.00688-06
Ghannoum, M. A. ; Arthington-Skaggs, B. ; Chaturvedi, V. ; Espinel-Ingroff, A. ; Pfaller, M. A. ; Rennie, R. ; Rinaldi, M. G. ; Walsh, T. J. / Interlaboratory study of quality control isolates for a broth microdilution method (Modified CLSI M38-A) for testing susceptibilities of dermatophytes to antifungals. In: Journal of Clinical Microbiology. 2006 ; Vol. 44, No. 12. pp. 4353-4356.
@article{6d39b14cf00548bd846da07a8ac07aad,
title = "Interlaboratory study of quality control isolates for a broth microdilution method (Modified CLSI M38-A) for testing susceptibilities of dermatophytes to antifungals",
abstract = "The Clinical and Laboratory Standards Institute (CLSI; formerly National Committee for Clinical Laboratory Standards, or NCCLS) M38-A standard for the susceptibility testing of filamentous fungi does not specifically address the testing of dermatophytes. In 2003, a multicenter study investigated the reproducibility of the microdilution method developed at the Center for Medical Mycology, Cleveland, Ohio, for testing the susceptibility of dermatophytes. Data from that study supported the introduction of this method for testing dermatophytes in the future version of the CLSI M38-A standard. In order for the method to be accepted by CLSI, appropriate quality control isolates needed to be identified. To that end, an interlaboratory study, involving the original six laboratories plus two additional sites, was conducted to evaluate potential candidates for quality control isolates. These candidate strains included five Trichophyton rubrum strains known to have elevated MICs to terbinafine and five Trichophyton mentagrophytes strains. Antifungal agents tested included ciclopirox, fluconazole, griseofulvin, itraconazole, posaconazole, terbinafine, and voriconazole. Based on the data generated, two quality control isolates, one T. rubrum isolate and one T. mentagrophytes isolate, were identified and submitted to the American Type Culture Collection (ATCC) for inclusion as reference strains. Ranges encompassing 95.2 to 97.9{\%} of all data points for all seven drugs were established.",
author = "Ghannoum, {M. A.} and B. Arthington-Skaggs and V. Chaturvedi and A. Espinel-Ingroff and Pfaller, {M. A.} and R. Rennie and Rinaldi, {M. G.} and Walsh, {T. J.}",
year = "2006",
month = "12",
doi = "10.1128/JCM.00688-06",
language = "English (US)",
volume = "44",
pages = "4353--4356",
journal = "Journal of Clinical Microbiology",
issn = "0095-1137",
publisher = "American Society for Microbiology",
number = "12",

}

TY - JOUR

T1 - Interlaboratory study of quality control isolates for a broth microdilution method (Modified CLSI M38-A) for testing susceptibilities of dermatophytes to antifungals

AU - Ghannoum, M. A.

AU - Arthington-Skaggs, B.

AU - Chaturvedi, V.

AU - Espinel-Ingroff, A.

AU - Pfaller, M. A.

AU - Rennie, R.

AU - Rinaldi, M. G.

AU - Walsh, T. J.

PY - 2006/12

Y1 - 2006/12

N2 - The Clinical and Laboratory Standards Institute (CLSI; formerly National Committee for Clinical Laboratory Standards, or NCCLS) M38-A standard for the susceptibility testing of filamentous fungi does not specifically address the testing of dermatophytes. In 2003, a multicenter study investigated the reproducibility of the microdilution method developed at the Center for Medical Mycology, Cleveland, Ohio, for testing the susceptibility of dermatophytes. Data from that study supported the introduction of this method for testing dermatophytes in the future version of the CLSI M38-A standard. In order for the method to be accepted by CLSI, appropriate quality control isolates needed to be identified. To that end, an interlaboratory study, involving the original six laboratories plus two additional sites, was conducted to evaluate potential candidates for quality control isolates. These candidate strains included five Trichophyton rubrum strains known to have elevated MICs to terbinafine and five Trichophyton mentagrophytes strains. Antifungal agents tested included ciclopirox, fluconazole, griseofulvin, itraconazole, posaconazole, terbinafine, and voriconazole. Based on the data generated, two quality control isolates, one T. rubrum isolate and one T. mentagrophytes isolate, were identified and submitted to the American Type Culture Collection (ATCC) for inclusion as reference strains. Ranges encompassing 95.2 to 97.9% of all data points for all seven drugs were established.

AB - The Clinical and Laboratory Standards Institute (CLSI; formerly National Committee for Clinical Laboratory Standards, or NCCLS) M38-A standard for the susceptibility testing of filamentous fungi does not specifically address the testing of dermatophytes. In 2003, a multicenter study investigated the reproducibility of the microdilution method developed at the Center for Medical Mycology, Cleveland, Ohio, for testing the susceptibility of dermatophytes. Data from that study supported the introduction of this method for testing dermatophytes in the future version of the CLSI M38-A standard. In order for the method to be accepted by CLSI, appropriate quality control isolates needed to be identified. To that end, an interlaboratory study, involving the original six laboratories plus two additional sites, was conducted to evaluate potential candidates for quality control isolates. These candidate strains included five Trichophyton rubrum strains known to have elevated MICs to terbinafine and five Trichophyton mentagrophytes strains. Antifungal agents tested included ciclopirox, fluconazole, griseofulvin, itraconazole, posaconazole, terbinafine, and voriconazole. Based on the data generated, two quality control isolates, one T. rubrum isolate and one T. mentagrophytes isolate, were identified and submitted to the American Type Culture Collection (ATCC) for inclusion as reference strains. Ranges encompassing 95.2 to 97.9% of all data points for all seven drugs were established.

UR - http://www.scopus.com/inward/record.url?scp=33845591155&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33845591155&partnerID=8YFLogxK

U2 - 10.1128/JCM.00688-06

DO - 10.1128/JCM.00688-06

M3 - Article

C2 - 17050812

AN - SCOPUS:33845591155

VL - 44

SP - 4353

EP - 4356

JO - Journal of Clinical Microbiology

JF - Journal of Clinical Microbiology

SN - 0095-1137

IS - 12

ER -